Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metsep M 3mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sepik Life Sciences

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Metsep M 3mg/500mg Tablet

DiabetaComb 3mg/500mg tablets are classified as antidiabetic agents, a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose in diabetic patients. DiabetaComb 3mg/500mg tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can lead to elevated glucose, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Primary Ingredients of Metsep M 3mg/500mg Tablet

There is no text provided to rephrase. Please provide the text you wish to have rewritten.

Uses of Metsep M 3mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Metsep M 3mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the Metsep M 3mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. It should be taken with a meal.

Common Side effects of Metsep M 3mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metsep M 3mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take the Metsep M 3mg/500mg Tablet with a meal.

How Metsep M 3mg/500mg Tablet works:

Metformin and Glimepiride 500mg/3mg tablets (Metsep M) offer a dual-action approach to diabetes management. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a three-pronged mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Metsep M 3mg/500mg tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Metsep M 3mg/500mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Patient consultation with their doctor is advised.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Metsep M 3mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metsep M 3mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Metsep M 3mg/500mg tablets. Consult a physician for guidance. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with hepatic impairment should use Metsep M 3mg/500mg tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Metsep M 3mg/500mg tablets are typically initiated at a reduced dosage; however, their use is contraindicated in patients with severe liver dysfunction.

What if you forget to take Metsep M 3mg/500mg Tablet :

Should you forget a Metsep M 3mg/500mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metsep M 3mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metsep M 3mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Metsep M 3mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Metsep M 3mg/500mg Tablets and seek immediate medical attention.
Metsep M 3mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Metsep M 3mg/500mg tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Metsep M 3mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Metsep M 3mg/500mg Tablets can cause hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. Hypoglycemia risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Metsep M 3mg/500mg tablets with alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and increased lactic acidosis.
Metsep M 3mg/500mg Tablet
128
MRP 148
13% off